| scholarly article | Q13442814 |
| P2093 | author name string | Antonio Oliver | |
| Nuria Borrell | |||
| José L Pérez | |||
| Maria D Maciá | |||
| P2860 | cites work | Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen | Q22122393 |
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
| Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia | Q29615286 | ||
| Lung infections associated with cystic fibrosis | Q30080000 | ||
| Escherichia coli mutator genes | Q33539352 | ||
| Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori | Q33952076 | ||
| Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients | Q33966881 | ||
| Mutator clones of Neisseria meningitidis in epidemic serogroup A disease | Q34028018 | ||
| Mutator bacteria as a risk factor in treatment of infectious diseases | Q34113782 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| The role of mutators in the emergence of antibiotic-resistant bacteria | Q35177659 | ||
| Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 | ||
| Genetics of Pseudomonas | Q37198130 | ||
| Transformation of Pseudomonas aeruginosa by electroporation | Q40540293 | ||
| Mismatch repair and the regulation of phase variation in Neisseria meningitidis | Q43612705 | ||
| Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test | Q43627836 | ||
| Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? | Q43874264 | ||
| High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains | Q44195004 | ||
| Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair | Q46617407 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli | Q56944671 | ||
| Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance | Q79162727 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| P304 | page(s) | 2665-2672 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion | |
| P478 | volume | 48 |
| Q41937031 | Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. |
| Q41098639 | Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations |
| Q92880978 | Antimicrobial Treatment Provides a Competitive Advantage to Mycobacterium abscessus in a Dual-Species Biofilm with Pseudomonas aeruginosa |
| Q36933558 | Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa |
| Q37794342 | Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance |
| Q34042263 | Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: use of high-range Etest strips. |
| Q34509793 | Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa |
| Q46608208 | Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy |
| Q33886303 | Epistatic roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in coping with reactive oxygen species-induced DNA damage |
| Q36667671 | Hypermutable Pseudomonas aeruginosa in Cystic fibrosis patients from two Brazilian cities. |
| Q41974061 | Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections |
| Q90335815 | In Situ Synthesis of Luminescent Au Nanoclusters on a Bacterial Template for Rapid Detection, Quantification, and Distinction of Kanamycin-Resistant Bacteria |
| Q42909082 | Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections. |
| Q28492865 | Influence of Pseudomonas aeruginosa pvdQ gene on altering antibiotic susceptibility under swarming conditions |
| Q95446534 | Influence of Pseudomonas aeruginosa pvdQ gene on altering antibiotic susceptibility under swarming conditions |
| Q35879111 | Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. |
| Q58164270 | Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients |
| Q57169588 | Meropenem combined with ciprofloxacin combats hypermutable from respiratory infections of cystic fibrosis patients |
| Q34998656 | Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices. |
| Q34117477 | Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections |
| Q36914772 | Network-assisted investigation of virulence and antibiotic-resistance systems in Pseudomonas aeruginosa |
| Q37002813 | Predicting antibiotic resistance |
| Q28299966 | Pseudomonas aeruginosa biofilms in cystic fibrosis |
| Q84781369 | Role of MexA-MexB-OprM efflux pump system in chronic Pseudomonas aeruginosa pulmonary infection in mice |
| Q64056369 | The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity |
| Q22065663 | The emergence of antibiotic resistance by mutation |
| Q28492495 | The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa |
| Q38300820 | The problems of antibiotic resistance in cystic fibrosis and solutions |
| Q83386827 | [Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis] |
| Q34180060 | siRNA-mediated gene silencing of MexB from the MexA-MexB-OprM efflux pump in Pseudomonas aeruginosa |
Search more.